Asciminib is a kind of BCR-ABL inhibitor. It’s made just for CML patients who couldn’t get better with other treatments. It’s a pill you take.
It goes straight for the ABL myristoyl pocket—it’s super important to that BCR-ABL fusion thing. You’ve got two doses—20 mg and 40 mg—both in those tablets with a coating. You should take it either 80 mg every day or 40 mg twice a day, whatever works best for you.
They come in bottles with 60 tablets each. It’s pretty handy if you’re on long-term treatment. Asciminib is a really important option for CML patients who’ve tried other treatments and they didn’t work.
